The All India Institute Of Medical Sciences (AIIMS) here will be starting Phase 2/3 trials of Hyderabad-based Covid-19 vaccine manufacturer Bharat Biotech's nasal vaccine soon, sources informed on Wednesday. Amid ongoing research in many countries to develop nasal spray to help prevent Covid-19, Bharat Biotech's intranasal vaccine received regulatory approval for second Phase trials in August.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3zUUuV3
Bollywood News And Much More In Gujarati Language. Gujarati Literature. Excellent Coverage. Premium Content. Most Accurate
No comments:
Post a Comment